APA (7th ed.) Citation

de Jonge, A. V., van Werkhoven, E., Dinmohamed, A. G., Nijland, M., Zwinderman, A. H., Bossuyt, P. M., . . . Chamuleau, M. E. D. (2023). A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients. Blood Cancer Journal, 13(1), . https://doi.org/10.1038/s41408-023-00854-2

Chicago Style (17th ed.) Citation

de Jonge, A. Vera, et al. "A Non-randomized Risk-adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC-rearranged DLBCL Patients." Blood Cancer Journal 13, no. 1 (2023). https://doi.org/10.1038/s41408-023-00854-2.

MLA (9th ed.) Citation

de Jonge, A. Vera, et al. "A Non-randomized Risk-adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC-rearranged DLBCL Patients." Blood Cancer Journal, vol. 13, no. 1, 2023, https://doi.org/10.1038/s41408-023-00854-2.